PROGENICS PHARM (NASDAQ:PGNX)

4.51

-0 (-0%)

PROGENICS PHARM (NASDAQ:PGNX) Delayed :
Previous Close	$4.51	52 Week High	$9.11
Open	$4.52	52 Week Low	$3.53
Day High	$4.52	P/E	N/A
Day Low	$4.36	EPS	$-1.45
Volume	67,092
More PGNX Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
WYE	3

View All Entities

Feb 4, 2010 09:18 AM Progenics Pharma (PGNX) Presents Data on Two Compounds Shown to Block Growth and Survival of Cancer Cells
Oct 16, 2009 11:43 AM Lazard Capital Upgrades Progenics Pharmaceuticals (PGNX) to Buy
Oct 16, 2009 11:19 AM Lazard Capital Upgrades Progenics Pharmaceutical (PGNX) to Buy
Oct 14, 2009 02:19 PM Needham Cuts Progenics (PGNX) to Hold Midday
Oct 14, 2009 07:25 AM Progenics Pharma (PGNX) Regains RELISTOR Rights from Wyeth (WYE)

Feb 4, 2010 08:00AM Progenics Presents Novel Multiplex PI3-Kinase Inhibitors at American Association for Cancer Research Conference on Protein Translation and Cancer

Jan 4, 2010 03:37 AM Biotech’s 2009 Stealth Small Cap Rally
Nov 20, 2009 06:07 AM A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
Nov 16, 2009 05:50 PM Progenics: Are the Prospects That Bad?
Oct 14, 2009 01:19 PM Progenics: Investors Are Right To Be Wary
Oct 14, 2009 12:09 PM BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics

Feb 9, 2010 11:39AM Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: TUDOR INVESTMENT CORP ET AL
Feb 4, 2010 02:44PM Form 8-K PROGENICS PHARMACEUTICAL For: Feb 04
Jan 29, 2010 03:02PM Form SC 13G PROGENICS PHARMACEUTICAL Filed by: BlackRock Inc.
Jan 6, 2010 03:17PM Form 4 PROGENICS PHARMACEUTICAL For: Jan 04 Filed by: Olson William C
Jan 6, 2010 03:16PM Form 4 PROGENICS PHARMACEUTICAL For: Jan 04 Filed by: MCKINNEY ROBERT A

No comments are currently available.